0.1934
-0.0043
(-2.18%)
At close: January 13 at 4:00:01 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.33 | -0.33 | -1.22 | 0 |
| Low Estimate | -0.33 | -0.33 | -1.22 | 0 |
| High Estimate | -0.33 | -0.33 | -1.22 | 0 |
| Year Ago EPS | -5.51 | -5.01 | -- | -1.22 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | -- |
| Avg. Estimate | 1.18M | 1.3M | 5.2M | -- |
| Low Estimate | 1.18M | 1.3M | 3.4M | -- |
| High Estimate | 1.18M | 1.3M | 7.01M | -- |
| Year Ago Sales | 891.16k | 929.63k | 3.43M | -- |
| Sales Growth (year/est) | 31.85% | 40.16% | 51.67% | -- |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -6.2 | -4.4 | -0.35 | -0.35 |
| EPS Actual | -5.51 | -5.01 | -0.82 | -0.31 |
| Difference | 0.69 | -0.61 | -0.47 | 0.04 |
| Surprise % | 11.06% | -13.80% | -133.46% | 12.29% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.33 | -0.33 | -1.22 | 0 |
| 7 Days Ago | 0 | 0 | -1.05 | 0 |
| 30 Days Ago | 0 | 0 | -1.05 | 0 |
| 60 Days Ago | 0 | 0 | -2.58 | 0 |
| 90 Days Ago | 0 | 0 | -2.58 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| APDN | 94.02% | 93.41% | -- | -- |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 6/10/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/9/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 12/8/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/24/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
Related Tickers
TTOO T2 Biosystems, Inc.
0.3200
0.00%
CHEK Check-Cap Ltd.
1.5000
-1.96%
PRPH ProPhase Labs, Inc.
0.6490
0.00%
ISPC iSpecimen Inc.
2.6800
0.00%
XGN Exagen Inc.
3.1200
-1.58%
STIM Neuronetics, Inc.
2.3400
+36.84%
PSNL Personalis, Inc.
5.35
-4.29%
MYNZ Mainz Biomed N.V.
4.6700
+9.11%
NDRA ENDRA Life Sciences Inc.
5.73
-2.63%
ICBU iMD Companies, Inc.
0.0025
+4.17%